Human infection duration (days) |
|
|
Latent period |
|
12 |
Patent infection |
|
195 |
Clinical disease (untreated) |
|
5 |
Treatment of clinical disease |
|
5 |
Sub-patent infection |
|
110.299 |
Prophylaxis |
|
15 |
Age and heterogeneity
|
|
|
Age-dependent biting parameter |
|
0.85 |
Age-dependent biting parameter |
|
8 years |
Variance of the log heterogeneity in biting rates |
|
1.67 |
Pre-erythrocytic immunity reducing probability of infection
|
|
|
Duration of refractory period in which immunity is not boosted |
|
7.19919 days |
Duration of pre-erythrocytic immunity |
|
10 years |
Maximum probability of infection due to no immunity |
|
0.590076 |
Maximum relative reduction in probability of infection due to immunity |
|
0.5 |
Scale parameter |
|
43.8787 |
Shape parameter |
|
2.15506 |
Immunity reducing probability of clinical disease
|
|
|
Duration of refractory period in which immunity is not boosted |
|
6.06349 days |
Duration of clinical immunity |
|
30 years |
New-born immunity relative to mother’s clinical immunity |
|
0.774368 |
Duration of maternal immunity |
|
67.6952 days |
Maximum probability of clinical disease due to no immunity |
|
0.791666 |
Maximum relative reduction in probability of clinical disease due to immunity |
|
0.000737 |
Scale parameter |
|
18.02366 |
Shape parameter |
|
2.36949 |
Immunity reducing probability of detection
|
|
|
Duration of refractory period in which immunity is not boosted |
|
9.44512 days |
Duration of detection immunity |
|
10 years |
Minimum probability of detection due to maximum immunity |
|
0.160527 |
Scale parameter |
|
1.577533 |
Shape parameter |
|
0.476614 |
Scale parameter relating age to immunity |
|
21.9 years |
Time-scale at which immunity changes with age |
|
0.007055 |
Shape parameter relating age to immunity |
|
4.8183 |